Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade

Gladys Ferrere; Maryam Tidjani Alou; Peng Liu; Anne‐Gaëlle Goubet; Marine Fidelle; Oliver Kepp; Sylvère Durand; Valerio Iebba; Aurélie Fluckiger; Romain Daillère; Cassandra Thélémaque; Claudia Grajeda‐Iglesias; Carolina Alves Costa Silva; Fanny Aprahamian; Déborah Lefevre; Liwei Zhao; Bernhard Ryffel; Émeline Colomba; Mónica Arnedos; Damien Drubay; Conrad Rauber; Didier Raoult; Francesco Asnicar; Tim D. Spector; Nicola Segata; Lisa Derosa; Guido Guido Kroemer; Laurence Zitvogel

doi:10.1172/jci

Related publications

Article2020

Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade

Gladys Ferrere, Maryam Tidjani Alou, Peng Liu, Anne‐Gaëlle Goubet, Marine Fidelle, Oliver Kepp, Sylvère Durand, Valerio Iebba, Aurélie Fluckiger, Romain Daillère, Cassandra Thélémaque, Claudia Grajeda‐Iglesias, Carolina Alves Costa Silva, Fanny Aprahamian, Déborah Lefevre, Liwei Zhao, Bernhard Ryffel, Émeline Colomba, Mónica Arnedos, Damien Drubay, Conrad Rauber, Didier Raoult, Francesco Asnicar, Tim D. Spector, Nicola Segata, Lisa Derosa, Guido Guido Kroemer, Laurence Zitvogel

Article2018

Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade

Joy Hsu, Jonathan J. Hodgins, Malvika Marathe, Chris J. Nicolai, Marie‐Claude Bourgeois‐Daigneault, Troy N. Trevino, Camillia S. Azimi, Amit Scheer, Haley E. Randolph, Thornton W. Thompson, Lily Zhang, Alexandre Iannello, Nikhita Mathur, Karen Jardine, Georgia Kirn, John C. Bell, Michael W. McBurney, David H Raulet, Michele Ardolino

Article2022

Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade

Discussion(0)

Related publications

Ketogenic diet and ketone bodies enhance the anticancer effects of PD-1 blockade

Contribution of NK cells to immunotherapy mediated by PD-1/PD-L1 blockade

Targeting HSP90 sensitizes pancreas carcinoma to PD-1 blockade

Immunotherapy of hematological cancers: PD-1 blockade for the treatment of Hodgkin's lymphoma

Clinical evidence that immunogenic cell death sensitizes to PD-1/PD-L1 blockade